The landscape of dementia prognosis has evolved substantially with the arrival of refined biomarkers, which includes amyloid PET scans, tau imaging, and blood-primarily based tests that can detect Alzheimer's pathology decades right before indications emerge. Although these technological developments represent outstanding progress in comprehending neurodegenerative illnesses, they hav... https://michaelj429irb9.life-wiki.com/user